Because of a $7 million award against Wyeth last week, allowing patients more ability to sue pharmaceutical companies, 2 lawsuits that accuse Pfizer Inc. and GlaxoSmithKline PLC of failing to warn that their drugs might cause suicidal tendencies, are being reexamined. A federal appeals court was told to reconsider suits that are charged by relatives of a woman who killed herself after taking Glaxo"s Paxil (paroxetine hydrochloride) and a man who committed suicide after taking Pfizer"s Zoloft (sertraline).